Literature DB >> 5682243

Aldosteronism in hypertension. The spironolactone response test.

R F Spark, J C Melby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5682243     DOI: 10.7326/0003-4819-69-4-685

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  25 in total

Review 1.  Diuretics: mechanism of action and clinical application.

Authors:  D L Davies; G M Wilson
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Hypertension with aldosterone excess.

Authors:  J J Brown; R Fraser; A F Lever; J I Robertson
Journal:  Br Med J       Date:  1972-05-13

3.  Aldosterone, angiotensin, and hypertension.

Authors: 
Journal:  Br Med J       Date:  1970-03-28

4.  Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.

Authors:  R M Carey; C R Ayers; E D Vaughan; M J Peach; S M Herf
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

5.  Suppression by the spironolactone metabolite canrenone of plasma testosterone in man.

Authors:  H C Erbler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

Review 6.  Diuretics. II. Clinical considerations.

Authors:  J L Anderton; P Kincaid-Smith
Journal:  Drugs       Date:  1971       Impact factor: 9.546

7.  Amiloride in primary hyperaldosteronism with chronic peptic ulceration.

Authors:  D Kremer; R Fraser; J J Brown; A F Lever; D L Davies; J I Robertson
Journal:  Br Med J       Date:  1973-04-28

8.  Hyperaldosteronism from adrenal carcinoma.

Authors:  R V Brooks; D Felix-Davies; M R Lee; P W Robertson
Journal:  Br Med J       Date:  1972-01-22

9.  Falsely high plasma potassium values in patients with hyperaldosteronism.

Authors:  J J Brown; R H Chinn; D L Davies; R Fraser; A F Lever; R J Rae; J I Robertson
Journal:  Br Med J       Date:  1970-04-04

Review 10.  Effect of antihypertensive drugs on the renin-angiotensin system.

Authors:  C I Johnston
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.